Discontinuation of biosimilar infliximab in Japanese patients with rheumatoid arthritis achieving sustained clinical remission or low disease activity during the IFX-SIRIUS STUDY I (the IFX-SIRIUS STUDY II) Study protocol for an interventional, multicenter, open-label, single-arm clinical trial with clinical, ultrasound and biomarker assessments

Shimizu, T; Kawashiri, SY; Sato, S; Morimoto, S; Minoda, S; Kawazoe, Y; Kuroda, S; Tashiro, S; Sumiyoshi, R; Hosogaya, N; Yamamoto, H; Kawakami, A

Kawashiri, SY (corresponding author), Nagasaki Univ, Dept Community Med, Div Adv Prevent Med Sci, Grad Sch Biomed Sci, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.

MEDICINE, 2020; 99 (32):

Abstract

Background: The introduction of biological disease-modifying anti-rheumatic drugs into clinical practice has dramatically improved the clinical outcom......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索